Rentokil RTO Buy Sell or Hold Rentokil posts 173 EPS miss vs analyst estimates SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading MEDP Medpace Holdings shares rise 435 percent after Q1 2026 EPS outpaces consensus analyst expectations CEPU Cent Puerto reports steep Q4 2024 earnings miss as shares post a small gain today MRDN Meridian Holdings delivers massive Q4 2025 EPS beat with shares gaining 302 percent today